Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel

Melanie D. Swift; Laura E. Breeher; Aaron J. Tande; Christopher P. Tommaso; Caitlin M. Hainy; Haitao Chu; M. Hassan Murad; Elie F. Berbari; Abinash Virk

doi:10.1093/cid/ciab361

Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel

Melanie D. Swift, Laura E. Breeher, Aaron J. Tande, Christopher P. Tommaso, Caitlin M. Hainy, Haitao Chu, M. Hassan Murad, Elie F. Berbari, Abinash Virk

Research output: Contribution to journal › Article › peer-review

Abstract

In a large cohort of United States healthcare personnel without prior coronavirus disease 2019 (COVID-19) infection, 94 382 doses of messenger RNA (mRNA) COVID-19 vaccine were administered to 49 220 individuals. The adjusted vaccine effectiveness following 2 doses of each of the 2 available brands of mRNA vaccine exceeded 96%.

Original language	English (US)
Pages (from-to)	E1376-E1379
Journal	Clinical Infectious Diseases
Volume	73
Issue number	6
DOIs	https://doi.org/10.1093/cid/ciab361
State	Published - Sep 15 2021

Keywords

COVID-19
SARS-CoV-2
healthcare personnel
mRNA
vaccine effectiveness

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1093/cid/ciab361

Cite this

Swift, M. D., Breeher, L. E., Tande, A. J., Tommaso, C. P., Hainy, C. M., Chu, H., Murad, M. H., Berbari, E. F., & Virk, A. (2021). Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel. Clinical Infectious Diseases, 73(6), E1376-E1379. https://doi.org/10.1093/cid/ciab361

Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel. / Swift, Melanie D.; Breeher, Laura E.; Tande, Aaron J. et al.
In: Clinical Infectious Diseases, Vol. 73, No. 6, 15.09.2021, p. E1376-E1379.

Research output: Contribution to journal › Article › peer-review

Swift, MD, Breeher, LE, Tande, AJ, Tommaso, CP, Hainy, CM, Chu, H, Murad, MH, Berbari, EF & Virk, A 2021, 'Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel', Clinical Infectious Diseases, vol. 73, no. 6, pp. E1376-E1379. https://doi.org/10.1093/cid/ciab361

@article{5530454f8c4d428c9250aab45046c7b4,

title = "Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel",

abstract = "In a large cohort of United States healthcare personnel without prior coronavirus disease 2019 (COVID-19) infection, 94 382 doses of messenger RNA (mRNA) COVID-19 vaccine were administered to 49 220 individuals. The adjusted vaccine effectiveness following 2 doses of each of the 2 available brands of mRNA vaccine exceeded 96%.",

keywords = "COVID-19, SARS-CoV-2, healthcare personnel, mRNA, vaccine effectiveness",

author = "Swift, {Melanie D.} and Breeher, {Laura E.} and Tande, {Aaron J.} and Tommaso, {Christopher P.} and Hainy, {Caitlin M.} and Haitao Chu and Murad, {M. Hassan} and Berbari, {Elie F.} and Abinash Virk",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2021.",

year = "2021",

month = sep,

day = "15",

doi = "10.1093/cid/ciab361",

language = "English (US)",

volume = "73",

pages = "E1376--E1379",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel

AU - Swift, Melanie D.

AU - Breeher, Laura E.

AU - Tande, Aaron J.

AU - Tommaso, Christopher P.

AU - Hainy, Caitlin M.

AU - Chu, Haitao

AU - Murad, M. Hassan

AU - Berbari, Elie F.

AU - Virk, Abinash

N1 - Publisher Copyright: © The Author(s) 2021.

PY - 2021/9/15

Y1 - 2021/9/15

N2 - In a large cohort of United States healthcare personnel without prior coronavirus disease 2019 (COVID-19) infection, 94 382 doses of messenger RNA (mRNA) COVID-19 vaccine were administered to 49 220 individuals. The adjusted vaccine effectiveness following 2 doses of each of the 2 available brands of mRNA vaccine exceeded 96%.

AB - In a large cohort of United States healthcare personnel without prior coronavirus disease 2019 (COVID-19) infection, 94 382 doses of messenger RNA (mRNA) COVID-19 vaccine were administered to 49 220 individuals. The adjusted vaccine effectiveness following 2 doses of each of the 2 available brands of mRNA vaccine exceeded 96%.

KW - COVID-19

KW - SARS-CoV-2

KW - healthcare personnel

KW - mRNA

KW - vaccine effectiveness

UR - http://www.scopus.com/inward/record.url?scp=85114793941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85114793941&partnerID=8YFLogxK

U2 - 10.1093/cid/ciab361

DO - 10.1093/cid/ciab361

M3 - Article

C2 - 33900384

AN - SCOPUS:85114793941

SN - 1058-4838

VL - 73

SP - E1376-E1379

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 6

ER -

Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this